Prof. Dr. Şükrü Tüzmen, B.S., M.S., Ph.D., is a distinguished molecular biologist and geneticist with extensive international academic and translational research experience. He earned his B.S., M.S., and Ph.D. degrees in Biology and Molecular Biology & Genetics from Boğaziçi University, one of the Ivy League Universities in Türkiye. He completed postdoctoral training as a Fogarty Fellow at the National Institutes of Health (NIH), Bethesda, MD, U.S.A., focusing on molecular genetics.
He currently serves as a Tenured Professor at Eastern Mediterranean University (EMU), Faculty of Dentistry and is the Founder/CEO of GenBiomics R&D in Cyprus. His career includes leadership roles at the Translational Genomics Research Institute (TGen AZ U.S.A.), adjunct professorships at Arizona State University (ASU), and the University of Maryland University College (UMGC), and extensive collaborations with institutions such as Mayo Clinic and ASU.
Prof. Tüzmen’s research centers on translational genomics, molecular diagnostics, RNAi-based therapeutics, and biomarker discovery. He has contributed to high-impact publications in cancer genomics, pharmacogenomics, and genetic disorders, including work on ARID1A tumor suppressor identification and RNAi-based drug target validation.
He is an active member and mentor within the European Society of Human Genetics (ESHG) and has served on multiple international scientific review panels. His recognitions include invited keynote lectures worldwide.
Prof. Dr. Şükrü Tüzmen, B.S., M.S., Ph.D., is a distinguished molecular biologist and geneticist with extensive international academic and translational research experience. He earned his B.S., M.S., and Ph.D. degrees in Biology and Molecular Biology & Genetics from Boğaziçi University, one of the Ivy League Universities in Türkiye. He completed postdoctoral training as a Fogarty Fellow at the National Institutes of Health (NIH), Bethesda, MD, U.S.A., focusing on molecular genetics.
He currently serves as a Tenured Professor at Eastern Mediterranean University (EMU), Faculty of Dentistry and is the Founder/CEO of GenBiomics R&D in Cyprus. His career includes leadership roles at the Translational Genomics Research Institute (TGen AZ U.S.A.), adjunct professorships at Arizona State University (ASU), and the University of Maryland University College (UMGC), and extensive collaborations with institutions such as Mayo Clinic and ASU.
Prof. Tüzmen’s research centers on translational genomics, molecular diagnostics, RNAi-based therapeutics, and biomarker discovery. He has contributed to high-impact publications in cancer genomics, pharmacogenomics, and genetic disorders, including work on ARID1A tumor suppressor identification and RNAi-based drug target validation.
He is an active member and mentor within the European Society of Human Genetics (ESHG) and has served on multiple international scientific review panels. His recognitions include invited keynote lectures worldwide.